These percentages highlighted the unmet needs in managing T2DM patients in Egypt, which could be attributed to the delay of insulin therapy, overuse of human insulin, overuse of vials, lack of diabetes education, and lack of healthcare support. The gene discussed is INS; the disease is type 2 diabetes mellitus.